ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 251 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $10,000 | +66.7% | 105 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $6,000 | -14.3% | 105 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $7,000 | 0.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | -12.5% | 105 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | 0.0% | 105 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $8,000 | +14.3% | 105 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $7,000 | +75.0% | 105 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $4,000 | -20.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $5,000 | 0.0% | 105 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $5,000 | -16.7% | 105 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $6,000 | +20.0% | 105 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $5,000 | +25.0% | 105 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $4,000 | -60.0% | 105 | -51.6% | 0.00% | -66.7% |
| Q3 2018 | $10,000 | -9.1% | 217 | -11.4% | 0.00% | -50.0% |
| Q2 2018 | $11,000 | -8.3% | 245 | -19.7% | 0.01% | -14.3% |
| Q1 2018 | $12,000 | -14.3% | 305 | -24.7% | 0.01% | -12.5% |
| Q4 2017 | $14,000 | +75.0% | 405 | +26.6% | 0.01% | +60.0% |
| Q3 2017 | $8,000 | +60.0% | 320 | 0.0% | 0.01% | +66.7% |
| Q2 2017 | $5,000 | – | 320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |